| Literature DB >> 26924942 |
Benjamin F Ricciardi1, Allina A Nocon2, Seth A Jerabek1, Gabrielle Wilner3, Elianna Kaplowitz3, Steven R Goldring3, P Edward Purdue3, Giorgio Perino4.
Abstract
BACKGROUND: Adverse local tissue reaction (ALTR), characterized by a heterogeneous cellular inflammatory infiltrate and the presence of corrosion products in the periprosthetic soft tissues, has been recognized as a mechanism of failure in total hip replacement (THA). Different histological subtypes may have unique needs for longitudinal clinical follow-up and complication rates after revision arthroplasty. The purpose of this study was to describe the histological patterns observed in the periprosthetic tissue of failed THA in three different implant classes due to ALTR and their association with clinical features of implant failure.Entities:
Keywords: Adverse local tissue reaction; Corrosion products; Hip resurfacing; Metal-on-metal total hip replacement; Revision arthroplasty; Synovial inflammation
Year: 2016 PMID: 26924942 PMCID: PMC4769839 DOI: 10.1186/s12907-016-0025-9
Source DB: PubMed Journal: BMC Clin Pathol ISSN: 1472-6890
Fig. 1Flowchart of case study selection. The flowchart summarizes the process for inclusion and exclusion criteria for the study during the time period June 2011-December 2014, starting with the total number of THA and HRA revisions performed during the study period and ending with the final number of cases examined
Histological grading system used for all cases of ALTR
| Synovial Structure | Cellularity | Macrophage Content | Bone and Bone Marrow Involvement |
|---|---|---|---|
| Synovial Layer Loss (Present, Absent) | Macrophages (Grade 0–3) | Polyethylene Particles (Present, Absent) | Necrosis (Present, Absent) |
| Cell Exfoliation (Present, Absent) | Lymphocytes (Grade 0–4) | Metal Particles (Present, Absent) | Macrophages (Present, Absent) |
| Soft Tissue Necrosis (Present, Absent) | Stromal Cells (Grade 1–3) | Corrosion Products (None, Intracellular, Extracellular) | Reactive Lymphocytic Aggregates (Present, Absent) |
| Vascular Wall Changes (Present, Absent) | Neutrophils (Present, Absent) | Germinal Centers (Present, Absent) | |
| Granulomas (Present, Absent) | Plasma Cells (Grade 0–2) | ||
| Eosinophils (Present, Absent) |
Histological patterns analyzed in hip replacement failures due to ALTR
| Histological Pattern | Characteristics |
|---|---|
| Macrophagic Pattern | Macrophagic infiltrate (grade ≥ 1) without or with minimal evidence of interstitial and/or perivascular lymphocytic infiltrate (<grade 1) |
| Mixed Macrophagic and Lymphocytic Pattern w/wo Plasmacytic Component | Macrophagic (grade ≥ 1) and lymphocytic (grade ≥ 1) infiltrate |
| Without Presence of Germinal Centers or Eosinophils | |
| With Presence of Germinal Centers or Eosinophils | |
| Granulomatous Pattern | Any pattern with predominant presence of sarcoid-like granulomas |
| Lymphocytic Pattern | Interstitial and/or perivascular lymphocytic infiltrate without evidence of macrophagic infiltrate |
Retrieved implants with failure due to ALTR
| Non-MoM DMNTHA | Number of Hips |
|---|---|
| Rejuvenate (Stryker, Kalamazoo, MI) | 111 |
| ABG II (Stryker, Kalamazoo, MI) | 5 |
| SMF (Smith and Nephew, London, UK) | 3 |
| Redapt (Smith and Nephew, London, UK) | 2 |
| OTI/Encore R-120 (DJO Surgical, Austin, TX) | 1 |
| Aesculap Hip Replacement (Aesculap, Hazelwood, MO) | 1 |
| MoM HRA | |
| Birmingham Hip Resurfacing (Smith and Nephew, London, UK) | 36 |
| Cormet Hip Resurfacing (Corin Group, Cirencester, UK) | 5 |
| Conserve Hip Resurfacing (Wright Medical Technology, Arlington, TN) | 2 |
| ASR Hip Resurfacing (Depuy/Synthes, Warsaw, IN) | 1 |
| MoM LHTHA | |
| Birmingham Hip Replacement (Smith and Nephew, London, UK) | 44 |
| ASR Hip Replacement (Depuy/Synthes, Warsaw, IN) | 22 |
| Pinnacle Ultramet (Depuy/Synthes, Warsaw, IN) | 19 |
| Durom/Metasul (Zimmer, Warsaw, IN) | 10 |
| M2a Magnum (Biomet, Warsaw, IN) | 8 |
| Profemur (Wright Medical Technology, Arlington, TX) | 6 |
| Metal on Metal Bearing S-ROM (Depuy/Synthes, Warsaw, IN) | 4 |
| Conserve Hip Replacement (Wright Medical Technology, Arlington, TN) | 4 |
| Cormet Hip Replacement (Corin Group, Cirencester, UK) | 1 |
Demographic characteristics from all three major implant classes
| Non-MoM DMNTHA ( | MoM HRA ( | MoM LHTHA ( | |
|---|---|---|---|
| Age (years) | 66 (47–87)* | 56 (43–75)* | 60 (31–84)* |
| Sex (% female) | 64 % | 58 % | 54 % |
| Body Mass Index | 28 (17–43)^ | 25 (18–36)^ | 26 (19–59) |
| Implantation Time (months) | 28 (6–65)° | 48 (5–120)° | 60 (23–132)° |
| Symptom Duration (months) | 9 (0–60) | 12 (0–63) | 18 (0–60) |
| Serum Cobalt | 7 (0–169)# | 16 (1–115)# | 13 (4–16)# |
| Serum Chromium | 1 (0–64)§ | 14 (1–160)§ | 60 (23–132)§ |
| Head Size | 28 (22–52)¶ | 46 (38–52)¶ | 46 (36–64)¶ |
| Cup Size | 52 (38–64) | 52 (46–58) | 52 (48–64) |
All values are given as median (range)
*p < 0.005 for the MoM HRA group compared to the other two groups
^p < 0.05 for the MoM HRA group compared to the non-MoM DMNTHA group (p = 0.005)
°p < 0.05 for the non-MoM-DMN THA group compared to the MoM HRA group (p < 0.001) and the MoM LHTHA group (p < 0.001)
# p < 0.05 for the non-MoM DMNTHA group compared to the MoM HRA group (p = 0.042)
§ p < 0.05 for the MoM HRA and the MoM LHTHA groups compared to the non-MoM DMNTHA group (p < 0.001) and the MoM HRA group compared to the MoM LHTHA group (p = 0.026)
¶ p < 0.05 for the MoM HRA (p < 0.001) and the MoM LHTHA (p < 0.001) groups compared to the non-MoM DMNTHA group
Distribution of the histological patterns in the three implant classes
| Implant class | Macrophagic pattern | Mixed Pattern w/o hypersensitivity features | Mixed Pattern w/Hypersensitivity Features | Granulomatous pattern | Lymphocytic pattern |
|---|---|---|---|---|---|
| Non-MoM DMNTHA | 6 | 46 | 32 | 16 | 0 |
| MoM HRA | 41 | 48 | 11 | 0 | 0 |
| MoM LHTHA | 11 | 62 | 22 | 5 | 0 |
All values are expressed as a percentage of total cases of each histological pattern for a specific implant class
Fig. 2Histological patterns of ALTR. Macrophagic pattern: a Papillary neo-synovium with macrophagic infiltrate and underlying vascular layer (H-E x50). b Vascular layer without lymphocytic infiltrate and cluster of particle laden macrophages, white arrow (H-E x400). Mixed macrophagic and lymphocytic pattern: c Neo-synovium with superficial macrophagic layer and desmoplastic band, white arrow, and perivascular lyphocytic infiltrate (H-E x50). d Perivascular lymphocytic infiltrate associated with large clusters of particle laden macrophages (H-E x200). Subset of the mixed pattern with heightened immunological features: e Neo-synovium with florid interstitial lymphocytic and eosinophilic infiltrate (H-E x200) and association of eosinophils with particle laden macrophages (inset, H-E x400). f Perivascular lymphocytic infiltrate with germinal center (H-E x200) associated with numerous mast cells (inset, Toluidine Blue x400). Granulomatous pattern: g Multiple sarcoid-like granulomas with central aggregate of corrosion products, white arrow (H-E x100). h Granuloma at higher power with central collection of epithelioid macrophages and occasional giant cells (H-E x200) and plasmacytic component with binucleated forms admixed with particle laden macrophages (inset, H-E x400)
Significant differences in histological findings from all three implant classes and the control group
| Non-MoM DMN | MoM HRA ( | MoM LHTHA ( | MoP OLTHA ( | |
|---|---|---|---|---|
| Synovial Structure | ||||
| Synovial Layer Loss (%) | 99 | 89 | 99 | 16.1 |
| Soft Tissue Necrosis (%) | 53‡ | 11‡ | 32‡ | 0‡ |
| Sarcoid-like Granulomas (%) | 16* | 0* | 5* | 0 |
| Campbell Score (median) | 8§ | 5§ | 6§ | - |
| Cellularity | ||||
| Macrophages (% Grade 1, Grade 2, Grade 3) | 7, 51, 42^ | 0, 5, 95^ | 1, 34, 65^ | 3, 16, 81^ |
| Lymphocytes (% Grade 1, Grade 2, Grade 3, Grade 4) | 7, 29, 34, 24° | 25, 18, 11, 7 ° | 25, 31, 23, 10° | 10, 0, 0, 0° |
| Plasma Cells (% Grade 1, Grade 2) | 26, 18 | 11, 9 | 29, 18 | 0, 0 |
| Eosinophils (%) | 20 | 9 | 17 | 0 |
| Macrophage Content | ||||
| Polyethylene Particles (%) | 2 | 0 | 0 | 80 |
| Metallic Particles (%) | 8# | 39# | 30# | 65# |
| Corrosion Products (%) | 95 | 100 | 99 | 0 |
| Large Aggregates | 74¶ | 11¶ | 63¶ | 0¶ |
| Bone and Bone Marrow |
|
|
|
|
| Necrosis (%) | 47 | 11 | 23 | - |
| Macrophage Infiltration (%) | 57 | 67 | 73 | - |
| Germinal Centers (%) | 12 | 2 | 3 | - |
| Osteolysis (# cases) | 4 | 9 | 4 | - |
All values for synovial structure, macrophage content, eosinophils, cell distributions, and bone and bone marrow content expressed as percentage of cases with each morphologic feature
*p = 0.013 for Non-MoM DMNTHA versus MoM LHTHA and MoM HRA
^p = 0.007 for OL versus Non-MoM DMNTHA; p = 0.007 for MoM HRA versus MoM LHTHA; MoM HRA versus Non-MoM DMNTHA, and Non-MoM DMNTHA versus MoM LHTHA
°p = 0.007 for significant difference in distributions of lymphocyte grade between all implant classes except MoM LHTHA versus MoM HRA (p = 0.0023)
# p = 0.007 for OL versus MoM LTHA and Non-MoM DMNTHA; p = 0.007 for Non-MoM DMNTHA versus MoM HRA and MoM LHTHA
§ p < 0.001 for significant difference in Campbell score between ALTR implant classes
‡p = 0.007 for OL versus Non-MoM DMNTHA, MoM LHTHA; p = 0.007 for MoM HRA versus Non-MoM DMNTHA; p = 0.009 MoM HRA versus MoM LHTHA; p = 0.0048 MoM LHTHA versus Non-MoM DMNTHA
¶p = 0.011 for OL versus MoM HRA; p = 0.007 OL versus Non-MoM DMNTHA and MoM LHTHA; p = 0.007 for MoM HRA versus MoM LHTHA and Non-MoM DMNTHA; p = 0.026 MoM LHTHA versus Non-MoM DMNTHA
Fig. 3Osteolysis features in the MoM RHA group. a Femoral head with orthopedic cement cap lined by papillary neo-synovium and showing osteolytic cavity involving the central groove of the metallic stem, white arrow (Smith and Nephew Birmingham, implantation time 48 months). b Content of the osteolytic cavity composed of particle laden macrophages with central exfoliation of necrotic forms in the right upper corner (H-E x100) and detail of the cavity lining cell layer containing greenish corrosion products in inset (x400). c Particle laden macrophagic infiltrate under the orthopedic cement cap lined by multinucleated giant cells (H-E x400). d Hematopoietic marrow with particle laden macrophages without evidence of lymphocytic reaction (H-E x400). e Femoral head with orthopedic cement cap lined by papillary neo-synovium with charcoal grey bone marrow, secondary to diffuse permeation by macrophagic infiltrate with metallic wear content (Smith and Nephew Birmingham, implantation time 78 months). f Massive macrophagic infiltrate in bone marrow containing greenish particles of corrosion products and black particles of abrasion metallic wear without evidence of osteoclastic activity (H-E x200). g Seeding of particle-laden macrophages in fatty marrow indicative of increased motility (H-E x100). h Large aggregate of lymphocytes positive for T-cell (CD3) and B-cell (CD20) marker (not shown) with interspersed particle laden macrophages, black arrows (H-E x 400)
Fig. 4Features of macrophagic pattern in the MoM LHTHA group. a Metallic femoral head and inserted metallic adapter sleeve (MAS) with groove filled with dense necrotic cellular debris (DePuy ASR, implantation time 61 months). b Papillary neo-synovium with florid macrophagic infiltrate and superficial exfoliation of necrotic forms (H-E x200). c Mixture of viable and necrotic particle laden macrophages of necrotic cellular debris shown in (A). d Necrotic cellular debris with entrapped large aggregates of greenish particulate corrosion products, black arrow (H-E x400). e Metallic femoral head and separate MAS (inset) with groove filled with dense necrotic cellular debris (Smith and Nephew Birmingham, implantation time 44 months). f Neo-synovium with florid macrophagic infiltrate and marked exfoliation of necrotic cellular debris (H-E x100). g Detail of the macrophgic infiltrate containing globular and irregular aggregates of greenish particulate corrosion products (H-E x400). h Cluster of aggregates of pale green corrosion products particles detected in smeared synovial fluid pellet spun at 3,000 rpm x 15 min (H-E x 400)
Fig. 5Features of corrosion products in the Non-MoM DMNTHA group. a MoP THA with CoCr dual exchangeable neck (inset) with corrosion on distal male taper (Stryker Rejuvenate, implantation time 20 months). b Neo-synovium showing superficial layer of macrophagic infiltrate and deep lymphocytic infiltrate (H-E x100). c Giant cell reaction without formation of granulomas to large aggregates of greenish and corrosion products (H-E x200). d Large aggregate of corrosion products with plate-like structure suggestive of layering of corrosion (greenish) and blood (reddish) products (H-E x400). e MoP THA with CoCr dual exchangeable neck with original CoC bearing surface and neck (inset, right upper corner) and second revision neck (inset, lower corner) with corrosion products on the male geared surface (OTI Encore, implantation time at first revision 36 months and at second revision 44 months from first revision). f Neo-synovium of first revision showing superficial layer of macrophagic infiltrate and dense layer of lymphocytic infiltrate (H-E x100). g Sarcoid-like granulomatous reaction with central green aggregates of corrosion products of second revision (H-E x100). h Large aggregate of layered corrosion products detached from the dual exchangeable neck (H-E x100) with scalloped shape of the gearing surface (inset)
Fig. 6Phases of macrophagic pattern of ALTR in MoM LHTHA prosthesis. Circle 1: Nano-scale particles generated at the bearing surface by sliding tribocorrosion and nano and micron-scale at the metallic adapter sleeve-femoral neck surface by fretting/crevice corrosion where larger aggregates are formed. Conventional abrasion metallic wear can also be generated at the bearing surface by edge loading and/or neck junction at any time of implantation. Circle 2: Phagocytosis/pinocytosis of particulate material by neo-synovial superficial and deep layer macrophages with multinucleated giant cells containing large particulate aggregates. Circle 3: Massive apoptosis of neo-synovial particle-laden macrophages through oxidative stress with formation of degenerated foamy forms (right side) and release of necrotic cellular debris and secondary particles of corrosion products/abrasion metallic particles with disruption of cytoplasmic phagosomes. Circle 4: Accumulation of viable macrophages, necrotic cellular debris, red blood cells, and entrapped small and large aggregates of primary and secondary particles of corrosion products in the femoral head groove with substantial increase in thickness of the synovial fluid and subsequent modification of its lubrication properties. Circle 5: Bone marrow involvement by neo-synovial particle-laden macrophagic infiltrate through resorptive osteoblastic activity and direct invasion through cortical gaps with formation of osteolytic cavity (right side), diffuse seeding of the fatty marrow (middle area), and involvement of the hematopoietic marrow (left side)